The Prothrombotic Tendency of Metabolic-Associated Fatty Liver Disease

The authors review the safety and efficacy of anticoagulation in advanced liver disease and consider whether antithrombotic agents could slow or halt the progression of fibrosis in metabolic-associated fatty liver disease.